Saunders J, Ashton M, Hall C, Laird B, MacLeod N
Beatson West of Scotland Cancer Centre, Glasgow G12 0YN, UK,
Institute of Cancer Sciences, University of Glasgow, UK.
Lung Cancer (Auckl). 2019 Apr 2;10:37-46. doi: 10.2147/LCTT.S192558. eCollection 2019.
Malignant pleural mesothelioma (MPM) is an aggressive cancer with a considerable symptom burden and poor prognosis. Focus on maintaining patients' quality of life and pain control is therefore paramount. Pain management in MPM is complex due to its multifactorial etiology resulting from direct tumor infiltration of the surrounding soft tissue, bone, and encasement of the intercostal nerves. A variety of treatment modalities, including pharmacological and non-pharmacological options, are often required to achieve adequate pain control in this challenging disease. This review article examines the current challenges and solutions available for pain management in MPM.
恶性胸膜间皮瘤(MPM)是一种侵袭性癌症,症状负担较重且预后较差。因此,关注维持患者的生活质量和控制疼痛至关重要。MPM的疼痛管理很复杂,因为其病因是多因素的,由肿瘤直接浸润周围软组织、骨骼以及肋间神经受包绕所致。在这种具有挑战性的疾病中,通常需要多种治疗方式,包括药物和非药物选择,来实现充分的疼痛控制。这篇综述文章探讨了MPM疼痛管理当前面临的挑战和可用的解决方案。